ARTICLE SUMMARY:
LEO Pharma's Cambridge-based Science & Tech Hub is scouting on its parent’s behalf for non-pharma technologies with potential application in dermatology. To date, the hub has signed numerous exploratory agreements with early-stage medtechs in such far-flung fields as jet propulsion and telecom. Also, MCRA’s Michael John talks about what’s coming next in CV devices, and we report on the accelerating migration of orthopedic procedures to ambulatory surgery centers.
